Endocyte Spiked Sharply On Rumored Resumption Of Cancer Drug Trial By: Benzinga via Benzinga June 30, 2014 at 15:49 PM EDT Endocyte (NASDAQ: ECYT) rose sharply in early afternoon trading Monday from near a 52-week low on rumors the company may resume a ... Read More >> Related Stocks: Endocyte Inc